ATLANTA, Oct. 16, 2019 /PRNewswire/ -- CryoLife, Inc.
(NYSE: CRY), a leading cardiac and vascular surgery company focused
on aortic disease, announced today that 2019 third quarter
financial results will be released on Wednesday, October 30, 2019 after the market
closes. On that day, the Company will hold a teleconference call
and live webcast at 5:30 p.m. ET to
discuss the results, followed by a question and answer session
hosted by Pat Mackin, Chairman,
President and Chief Executive Officer of CryoLife, Inc.
To listen to the live teleconference, please dial 201-689-8261 a
few minutes prior to 5:30 p.m. ET. A
replay of the teleconference will be available October 30 through November 6 and can be accessed
by calling (toll free) 877-660-6853 or 201-612-7415. The conference
number for the replay is 13695440.
The live webcast and replay can be accessed in the Investor
Relations section of the CryoLife website at www.cryolife.com and
selecting Webcasts & Presentations. In addition, a copy of the
earnings press release, which will contain financial and
statistical information for the completed quarter and full year,
can be accessed in the Investor Relations section of the CryoLife
website.
About CryoLife, Inc.
Headquartered in suburban Atlanta,
Georgia, CryoLife is a leader in the manufacturing,
processing, and distribution of medical devices and implantable
tissues used in cardiac and vascular surgical procedures focused on
aortic repair. CryoLife markets and sells products in more than 100
countries worldwide. For additional information about CryoLife,
visit our website, www.cryolife.com.
Contacts:
|
|
|
|
|
|
|
|
CryoLife
D. Ashley
Lee
Executive Vice
President, Chief Financial Officer
and Chief Operating Officer
Phone:
770-419-3355
|
|
|
Gilmartin Group
LLC
Greg Chodaczek / Lynn
Lewis
Phone:
646-924-1769
investors@cryolife.com
|
View original content to download
multimedia:http://www.prnewswire.com/news-releases/cryolife-announces-release-date-and-teleconference-call-details-for-2019-third-quarter-financial-results-300940026.html
SOURCE CryoLife, Inc.